PRX and MYL Related Headlines

Go Back

Aug 24, 2012 08:05AM Needham & Company Maintains a 'Hold' on Par Pharmaceutical (PRX); Is Endo (ENDP) the 'Mystery Bidder'
Aug 24, 2012 07:59AM Needham & Company on Endo Pharmaceuticals (ENDP): Watson (WPI) Gains First Generic Lidoderm Approval; A Few Other Issues Too
Jul 20, 2012 08:31AM Needham & Company maintains a 'Strong Buy' on Mylan (MYL); PRX Grossly Undervalued by TGP, MYL/PRX Instead As Strong Combo
Jul 18, 2012 10:26AM Somaxon (SOMX) Shares Double on Silenor Settlement, Strong Sales Outlook
Jul 17, 2012 04:12PM Somaxon (SOMX), Mylan (MYL), Par Pharma (PRX) Enter Silenor Settlement
Jul 17, 2012 04:11PM Somaxon Pharmaceuticals (SOMX) Announces Settlement Agreement of Silenor Patent; Updates Revenues
Jul 16, 2012 02:39PM Leerink Swann Downgrades Par Pharmaceutical (PRX) to Market Perform; Not Expecting Mylan (MYL) To Up The Ante
Jul 16, 2012 08:05AM Par Pharmaceutical (PRX) Peers On Watch After Deal (TEVA) (MYL) (WPI)

PRX and MYL Related Press Releases

Go Back

PRX and MYL Related SEC Filings

Go Back